BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
93 results:

  • 1. Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
    Schwartz CJ; Khorsandi N; Blanco A; Mukhtar RA; Chen YY; Krings G
    Breast Cancer Res Treat; 2024 Feb; 204(1):171-179. PubMed ID: 38091153
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Case Study on ppm1d and 9 Other Shared Germline Alterations in a Family.
    Biswas S; Manekar S; Bakshi SR
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):2129-2134. PubMed ID: 37378944
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors.
    Fito-Lopez B; Salvadores M; Alvarez MM; Supek F
    BMC Biol; 2023 Apr; 21(1):92. PubMed ID: 37095494
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.
    Mayerhofer C; Sedrak MS; Hopkins JO; Li T; Tayob N; Faggen MG; Sinclair NF; Chen WY; Parsons HA; Mayer EL; Lange PB; Basta AS; Perilla-Glen A; Lederman RI; Wong AR; Tiwari A; McAllister SS; Mittendorf EA; Gibson CJ; Burstein HJ; Kim AS; Freedman RA; Miller PG
    J Natl Cancer Inst; 2023 Aug; 115(8):981-988. PubMed ID: 37042724
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary breast cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
    Radosa JC; Solomayer EF; Deeken M; Minko P; Zimmermann JSM; Kaya AC; Radosa MP; Stotz L; Huwer S; Müller C; Karsten MM; Wagenpfeil G; Radosa CG
    Ann Surg Oncol; 2022 Aug; 29(8):4764-4772. PubMed ID: 35486266
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
    Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
    Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature).
    Vodolazhsky DI; Mayakovskaya AV; Kubyshkin AV; Aliev KA; Fomochkina II
    Klin Lab Diagn; 2021 Dec; 66(12):760-767. PubMed ID: 35020290
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
    Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
    J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel assay for screening wip1 phosphatase substrates in nuclear extracts.
    Storchova R; Burdova K; Palek M; Medema RH; Macurek L
    FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Systematic Review and Meta-Analysis of Sentinel Lymph Node Biopsy in Gastric cancer, an Optimization of Imaging Protocol for Tracer Mapping.
    Huang Y; Pan M; Chen B
    World J Surg; 2021 Apr; 45(4):1126-1134. PubMed ID: 33389000
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Stolarova L; Kleiblova P; Janatova M; Soukupova J; Zemankova P; Macurek L; Kleibl Z
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322746
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. wip1 controls the translocation of the chromosomal passenger complex to the central spindle for faithful mitotic exit.
    Zhang X; Park JE; Kim EH; Hong J; Hwang KT; Kim YA; Jang CY
    Cell Mol Life Sci; 2021 Mar; 78(6):2821-2838. PubMed ID: 33067654
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by wip1 inhibition.
    Wang J; Wang G; Cheng D; Huang S; Chang A; Tan X; Wang Q; Zhao S; Wu D; Liu AT; Yang S; Xiang R; Sun P
    Oncogene; 2020 Oct; 39(40):6313-6326. PubMed ID: 32848211
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of Malignant breast Lesions Using High-resolution Readout-segmented Diffusion-weighted Echo-planar Imaging: Comparison with Pathology.
    Kishimoto AO; Kataoka M; Iima M; Honda M; Miyake KK; Ohashi A; Ota R; Kataoka T; Sakurai T; Toi M; Togashi K
    Magn Reson Med Sci; 2021 Jun; 20(2):204-215. PubMed ID: 32611938
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. wip1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors.
    Burdova K; Storchova R; Palek M; Macurek L
    Cells; 2019 Oct; 8(10):. PubMed ID: 31619012
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis.
    Slavin TP; Sun CL; Chavarri-Guerra Y; Sedrak MS; Katheria V; Castillo D; Herzog J; Dale W; Hurria A; Weitzel JN
    J Geriatr Oncol; 2020 Mar; 11(2):316-319. PubMed ID: 31575519
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Somatic mosaic truncating mutations of ppm1d in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
    Kim B; Won D; Lee ST; Choi JR
    PLoS One; 2019; 14(6):e0217521. PubMed ID: 31242196
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detectible mosaic truncating ppm1d mutations, age and breast cancer risk.
    Machiela MJ; Myers TA; Lyons CJ; Koster R; Figg WD; Colli LM; Jessop L; Ahearn TU; Freedman ND; García-Closas M; Chanock SJ
    J Hum Genet; 2019 Jun; 64(6):545-550. PubMed ID: 30850729
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. IL-1β Inflammatory Cytokine-Induced
    Mendoza-Rodríguez MG; Ayala-Sumuano JT; García-Morales L; Zamudio-Meza H; Pérez-Yepez EA; Meza I
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641908
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.